bpc-157 nasal vs oral Spray vs. Injections BPC-157 + TB-500 Nasal Spray
Description
95% CI 87.60 to 26.76
The behavioral component cannot be overstated
The cumulative lifetime intake of LDopa and serum MMA levels might correlate with the extent of PN progression and severity (Mller 2008)
The decision shouldnt be based on convenience alone
Potential therapies Although some researchers have attempted to establish a treatment for ME/CFS and no reproducible results have been found (60), some treatments seem promising in ME/CFS ( Figure 13 )
